Design and lead the U.S. field reimbursement team for the launch of deramiocel, a cell therapy for Duchenne muscular dystrophy.
Partner with payer strategy, hub vendor, and cross-functional teams to ensure compliant patient access and reimbursement.
Own field reimbursement SOPs, budget, and team performance while capturing insights to shape market access strategy.
Capricor Therapeutics is a biotechnology company advancing transformative cell and exosome-based therapies for rare diseases. It is a publicly traded, mission-driven organization with a collaborative culture focused on scientific rigor and execution.
Establishes relationships with key opinion leaders and healthcare professionals in the assigned territory.
Serves as a scientific resource and expert for Mirum's rare disease liver portfolio.
Supports medical affairs activities including advisory boards, congress staffing, and investigator-initiated research.
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. The team is collaborative, creative, and passionate about advancing scientific discoveries for rare disease patients.
Establish, grow, and lead the national field-based MSL team, defining operational frameworks and best practices.
Oversee field-based support of clinical trials and strategic engagement of key thought leaders.
Ensure high standards of scientific excellence and compliance with all applicable regulations.
Orca Bio is a commercial-stage biotechnology company redefining the transplant process by developing next-generation cell therapies for blood cancer patients. With a small, entrepreneurial team, they maintain a start-up culture of camaraderie and leadership by example.
Develop and maintain senior payer relationships across a ten-state Northeast territory.
Lead account strategy for 16 accounts including Highmark, Independence, Point32Health, and UPMC.
Coordinate cross-functionally to resolve access barriers and support rare disease launches.
BridgeBio is a biopharmaceutical company using a 'moneyball for biotech' model to advance early-stage research and develop rare disease treatments. It values curiosity, experimentation, and boundary-pushing, fostering a collaborative culture with respected industry minds.
Lead and develop a team of Medical Science Liaisons (MSLs) in a designated geographic region to achieve scientific and business objectives.
Coach and mentor MSLs to enhance their performance, scientific knowledge, and strategic impact.
Collaborate cross-functionally to align field activities with broader medical objectives and ensure compliance.
AbbVie is a global biopharmaceutical company dedicated to discovering and delivering innovative medicines for serious health issues in immunology, oncology, and neuroscience. They foster a collaborative and inclusive culture to drive scientific excellence.
Lead U.S. trade and distribution strategy for rare disease gene therapy portfolio.
Manage partnerships with specialty distributors, pharmacies, and third-party logistics providers.
Ensure launch readiness and operational excellence while collaborating cross-functionally.
REGENXBIO is a biotechnology company focused on developing gene therapies for rare diseases. The company is a growing organization with a collaborative culture, emphasizing trust, accountability, perseverance, and innovation.
Lead commercial operations and analytics for the U.S. launch of deramiocel, a cell therapy for Duchenne muscular dystrophy.
Build and oversee commercial data ecosystem, analytics, forecasting, and field operations.
Establish scalable processes, governance, and cross-functional partnerships to drive launch readiness.
Capricor Therapeutics is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. The company is publicly traded and fosters a collaborative, mission-driven culture focused on innovation and patient impact.